Neuralstem, Inc. is a biotechnology company focused on developing and commercializing human neural stem cell technology in the field of regenerative medicine. The Company manufactures its cells both in-house and on an outsource basis. It uses these cells in its research grant and collaborative programs. The Company outsources all the manufacturing and storage of its stem cells to be used in pre-clinical works to Charles River Laboratories, Inc., of Wilmington, Massachusetts. The Charles River facility has the capacity to be used for cell processing under the United States Food and Drug Administration (FDA) determined good manufacturing practices (GMP) in quantities sufficient for its current pre-trial and anticipated future clinical trial needs. As of December 31, 2008, the Company had not identified any specific product.